Granules India arm gets ANDA approval for colchicine capsules
These capsules are equivalent to mitigare capsules', 0.6 mg, by Hikma International Pharmaceuticals LLC, and are indicated for the prophylaxis of gout flares in adults.30-04-2024
30-04-2024
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Receipt of ANDA approval for Colchicine Capsules30-04-2024
GRANULES INDIA LTD.-$ - 532482 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for FY 2418-04-2024
GRANULES INDIA LTD.-$ - 532482 - Compliance Certificate Under Regulation 40(10) Of The SEBI (LODR) Regulations, 2015
Compliance Certificate under Regulation 40(10) of the SEBI (LODR) Regulations, 201517-04-2024
GRANULES INDIA LTD.-$ - 532482 - Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations, 2015
Compliance Certificate under Regulation 7(3) of the SEBI(LODR) Regulations, 201515-04-2024
Granules India trades down despite zero observation from US FDA
Granules India Share Price | The share touched a 52-week high of Rs 480.50 and a 52-week low of Rs 272.00 on 26 February, 2024 and 25 May, 2023, respectively.15-04-2024
GRANULES INDIA LTD.-$ - 532482 - US FDA Audit For Granules India'S Unit V Facility Results In Zero 483S
US FDA audit for Granules India''s Unit V facility results in Zero 483s12-04-2024
GRANULES INDIA LTD.-$ - 532482 - Update Under Regulation 30 (LODR)
Update under Regulation 30 (LODR)10-04-2024